Magdalena Chorazka1, Domenica Flury2, Kathrin Herzog3, Werner C Albrich2, Danielle Vuichard-Gysin1,4. 1. Department of Internal Medicine, Cantonal Hospital Muensterlingen, Thurgau Hospital Group, Muensterlingen, Switzerland. 2. Department of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. 3. Department of Clinical Microbiology, Thurgau Hospital Group, Muensterlingen, Switzerland. 4. Department of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital Muensterlingen, Thurgau Hospital Group, Muensterlingen, Switzerland.
Abstract
OBJECTIVES: Respiratory syncytial virus (RSV) can cause severe disease in adults, but far less is known than for influenza. The aim of our study was to compare the disease course of RSV infections with influenza infections among hospitalized adults. METHODS: We retrieved clinical data from an ongoing surveillance of adults hospitalized with RSV or influenza virus infection in two acute care hospitals in North-Eastern Switzerland during the winter seasons 2017/2018 and 2018/2019. Our main analysis compared the odds between RSV and influenza patients for admission to an intensive care unit (ICU) or in-hospital death within 7 days after admission. RESULTS: There were 548 patients, of whom 79 (14.4%) had an RSV and 469 (85.6%) an influenza virus infection. Both groups were similar with respect to age, sex, smoking status, nutritional state, and comorbidities. More RSV patients had an infiltrate on chest radiograph on admission (46.4% vs 29.9%, p = .007). The proportion of patients with RSV who died or were admitted to ICU within seven days after admission was 19.0% compared to 10.2% in influenza patients (p = .024). In multivariable analysis, a higher leukocyte count (adjusted OR 1.07, 95% CI 1.02-1.13, p = .013) and the presence of a pneumonic infiltrate (aOR 3.41, 95% CI 1.93-6.02) significantly increased the risk for experiencing the adverse primary outcome while the effect of the underlying viral pathogen became attenuated (aOR 1.18, 95% CI 0.58-2.41, p = .0.655). CONCLUSIONS: Our results suggest that RSV is responsible for clinical courses at least as severe as influenza in adults. This supports the need for better guidance on diagnostic strategies as well as on preventive and therapeutic measures for hospitalized adults with RSV infection.
OBJECTIVES:Respiratory syncytial virus (RSV) can cause severe disease in adults, but far less is known than for influenza. The aim of our study was to compare the disease course of RSV infections with influenza infections among hospitalized adults. METHODS: We retrieved clinical data from an ongoing surveillance of adults hospitalized with RSV or influenzavirus infection in two acute care hospitals in North-Eastern Switzerland during the winter seasons 2017/2018 and 2018/2019. Our main analysis compared the odds between RSV and influenzapatients for admission to an intensive care unit (ICU) or in-hospital death within 7 days after admission. RESULTS: There were 548 patients, of whom 79 (14.4%) had an RSV and 469 (85.6%) an influenzavirus infection. Both groups were similar with respect to age, sex, smoking status, nutritional state, and comorbidities. More RSVpatients had an infiltrate on chest radiograph on admission (46.4% vs 29.9%, p = .007). The proportion of patients with RSV who died or were admitted to ICU within seven days after admission was 19.0% compared to 10.2% in influenzapatients (p = .024). In multivariable analysis, a higher leukocyte count (adjusted OR 1.07, 95% CI 1.02-1.13, p = .013) and the presence of a pneumonic infiltrate (aOR 3.41, 95% CI 1.93-6.02) significantly increased the risk for experiencing the adverse primary outcome while the effect of the underlying viral pathogen became attenuated (aOR 1.18, 95% CI 0.58-2.41, p = .0.655). CONCLUSIONS: Our results suggest that RSV is responsible for clinical courses at least as severe as influenza in adults. This supports the need for better guidance on diagnostic strategies as well as on preventive and therapeutic measures for hospitalized adults with RSV infection.
Authors: Daniel M Cohen; Jennifer Kline; Larissa S May; Glenn Eric Harnett; Jane Gibson; Stephen Y Liang; Zubaid Rafique; Carina A Rodriguez; Kevin M McGann; Charlotte A Gaydos; Donna Mayne; David Phillips; Jason Cohen Journal: J Clin Microbiol Date: 2018-01-24 Impact factor: 5.948
Authors: Clare E French; Bruce C McKenzie; Caroline Coope; Subhadra Rajanaidu; Karthik Paranthaman; Richard Pebody; Jonathan S Nguyen-Van-Tam; Julian P T Higgins; Charles R Beck Journal: Influenza Other Respir Viruses Date: 2016-03-24 Impact factor: 4.380
Authors: Gonçalo Matias; Robert Taylor; François Haguinet; Cynthia Schuck-Paim; Roger Lustig; Vivek Shinde Journal: BMC Public Health Date: 2017-03-21 Impact factor: 3.295
Authors: P Loubet; N Lenzi; M Valette; V Foulongne; A Krivine; N Houhou; G Lagathu; S Rogez; S Alain; X Duval; F Galtier; D Postil; P Tattevin; P Vanhems; F Carrat; B Lina; O Launay Journal: Clin Microbiol Infect Date: 2016-11-27 Impact factor: 8.067
Authors: Edward A Belongia; Jennifer P King; Burney A Kieke; Joanna Pluta; Ali Al-Hilli; Jennifer K Meece; Vivek Shinde Journal: Open Forum Infect Dis Date: 2018-11-27 Impact factor: 3.835
Authors: Shelley E Ellis; Christopher S Coffey; Edward F Mitchel; Robert S Dittus; Marie R Griffin Journal: J Am Geriatr Soc Date: 2003-06 Impact factor: 5.562
Authors: Sara Debes; Jon Birger Haug; Birgitte Freiesleben de Blasio; Jonas Christoffer Lindstrøm; Christine Monceyron Jonassen; Susanne Gjeruldsen Dudman Journal: Front Med (Lausanne) Date: 2022-04-29